Thursday, March 24, 2011
MU F2Q2011 Earnings Report
Due to 23% decrease in averaging selling prices, sales of DRAM were 6% lower compare to the first quarter. However sales of NAND flash memory chips were up 8% compare to the first quarter. The gross margin was 19%.Cash flows from operations for the second quarter of fiscal 2011 were $809 million. During the second quarter of fiscal 2011, the company invested $840 million in capital expenditures.
According to Micron's CEO, Steve Appleton, the downturn bottomed this quarter and the demand from the majority of the customers is improving. Management sees a continued improving pricing environment through the rest of the fiscal year.However some of the Micron's suppliers in Japan were affected by the earthquake and it will take couple of weeks to assess impact on the business.
-Vlad
Friday, March 18, 2011
NKE 3Q Results – First Miss Since ‘06
NKE traded down as much as 11% on the EPS miss and gross margin concerns through the back half of 2011. 3Q gross margin contracted 110 basis points compared to 2010, and management expects to see a 300 bps decrease in 4Q. The gross margin pressure is caused by rising sourcing costs which will force higher pricing points. This, however, is an issue facing many companies throughout the sector and we believe NKE will be able to effectively manage gross margins through 2H11.
Despite the aggressive sell-off today, we are still bullish on Nike’s story and fundamentals. Futures orders for branded products scheduled for delivery from March to July totaled $7.9bn, an increase of 9% compared to last year. NKE remains an innovator in the industry and the brand continually shows strength, and we are reticent to sell at this time given the long-term potential upside in the name.
-Ian
Tuesday, March 8, 2011
WDC Rally
The acquisition will result in a customer-focused storage facility that has a large operating scale, excellent talent, and the industry’s broadest product line. WDC has stated the acquisition will be immediately accretive, meaning WDC should enjoy increased EPS in coming quarters.
UASBIG Technology analysts are excited to see this acquisition take place. The sector is confident the company’s acquisition of Hitachi GST will strengthen the company’s competitive advantage and financial position in the industry.
-Chad
Tuesday, March 1, 2011
Endo Pharma Beats Earnings Expectations
Endo Pharmaceuticals reported strong earnings for 4Q 2010, as well as raising its guidance for full-year 2011. Revenue for fourth quarter increased 31% over the same period during 2009, with net income increasing from just $14.8 million to $93 million. Diluted EPS for the quarter was $0.77, compared with $1.25 for the fourth quarter of 2009, however adjusted EPS was $1.06 for the quarter compared with $0.81reported in 2009. For full-year 2010, Endo’s revenue increased 17.5% over 2009 reporting revenue of $1.76 billion. In addition, net income for FY 2010 fell from 2009, with Endo reporting net income of $259 million. Furthermore, Endo’s management team has raised its FY 2011 guidance to a range of $2.43 to $2.53 for GAAP diluted EPS, with a revenue range of $2.35 billion to $2.45 billion. Results of selected products and segments follow:
Lidoderm – FY 2010 sales for Endo’s headline product increased 2% year over year, reporting revenue of $783 million for 2010, compared with $764 during 2009 for the topical painkiller.
Opana ER & Opana – The branded painkiller franchise reported revenue of $299 million, which represents a 30% increase over 2009.
Generics – Net sales for Endo’s generic portfolio were $147 million in comparison to sales of $125 million recorded in 2009. This total does include sales from Qualitest Pharmaceuticals as of December 1, 2010.
Devices & Services – Revenue from Endo’s newly acquired HealthTronics subsidiary was $102 million for FY 2010.
-Dave Siegel
Thursday, February 24, 2011
Hewlett Packard downgraded
Chris Whitmore, analyst at Deutsche Bank.
"We believe it could be a rocky road going forward as the transition to a revenue-driven story will likely take considerable time,"
A Huge Disappointment is the delay in the debut of the Webos Touchpad the "Timing of all our WebOS products (and) Wi-Fi version of TouchPad available in summer in the US, and rest of the world in the fall." This has already been delayed tremendously. It will be very difficult HP to gain strong makret share while Apple will most likely have their second generation Ipad out by then.
Jonathan Wiener
Wednesday, February 23, 2011
Hewlett Packard Earnings HPQ, Q1
On the positive side HP has many new products that are going to be released in the coming year. They have the touchpad which I believe will be able to take a small share in the tablet market. With the acquisition of palm HP has decided to come out with their own line of cell phones. The most innovative release is the revitalization of their laptops since Personal computer sales have dropped this quarter this is vital for their comeback in that segment. The new laptop elite line allegedly will be able to get up 32 hrs a charge this will equate to tremendous sales if it is true.
At the moment I believe we will ride out this wave till the end of the week and I will post tomorrow with updated valuations based on the information that has been put out.
Jonathan Wiener
Friday, February 18, 2011
ECL F4Q10 Earnings 02/17/11-(Jim Carroll)
Net sales were up $ 1575.5 Million in the 4th quarter. Total revenues for the fiscal year of 2010 rose 3 %( year over year) to $6089.7 Million. ECL results were primarily from their Latin America and Asia Pacific sales. As well as, the global lodging and food and beverage businesses.The US Cleaning and Sanitizing business grew 1% to $681 million for the 4Q. ‘Other US Services’ rose $ 111 million. International operations jumped 3 % to $681 million. Overall, Operation Margins grew from 12.9% from 12.5%. Gross Margin increased marginally from 50.1 % to 50.3%.For 2011, ECL predicts their EPS to be between $2.47- $2.53.
ECL was just shy of earnings prompting shares to drop 5.3 % to $ 47.10, on February 17th. In the 4 Q ECL made acquisitions that analysts feel may put the company at risk. There has also been increased competition from Clorox (CLX) and Church and Dwight (CHD). J.P. Morgan even stated that so far in 2011, they are at the ‘bottom’ of the chemical universe. Ecolab, for the first quarter of 2011, estimates EPS to be 42 cents to 45 cents per share, which is below the average estimates of 48 cents a share. Ecolab created a restructuring plan in Europe, which will cut 900 jobs.
ECL plans to improve sales and to offset the cost of raw materials with new product releases and better pricing. In November, ECL acquired O.R solutions and they closed the deal for the Cleantec business from Campbell’s Brothers Ltd. O.R solutions is U.S. developer of surgical fluid warming and cooling systems. The Cleantec business, based out of Australia, is a developer of cleaning and hygiene products. On February 14th Ecolab released a disposable helmet system for use in surgical procedures. They feel that this will give surgeons the protection barrier they need and maintain a level of comfort.
-Jim Carroll